Dr. Martin B. Leon

Martin B. Leon

Interventional cardiologist / Cardiologist
Columbia University Medical Center - New York, United States

Dr. Leon received his medical degree from the Yale School of Medicine and completed his internal medicine internship, residency and cardiology fellowship at the Yale-New Haven Hospital. He is currently a Professor of Medicine at Columbia University’s Center for Interventional Vascular Therapy (CIVT) at New York-Presbyterian Hospital/Columbia University Medical Center and serves on the Executive Board of the New York-Presbyterian/Columbia Heart Valve Center. Marty was previously the Director of Cardiovascular Research and Education at the Lenox Hill Hospital, as well as the Director of Clinical Research at the Washington Cardiology Center.

 
Marty was the Founder of the Cardiovascular Research Foundation (CRF) in New York City and is currently CRF’s Co-Director of the Medical Research and Education Division.  He founded and directed Transcatheter Cardiovascular Therapeutics (TCT), dedicated to interventional cardiovascular medicine, which celebrated its 28th anniversary last year.  A distinguished pioneer in interventional cardiovascular medicine, Dr. Leon has been the national Principal Investigator for multiple landmark clinical trials, including STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and, most recently, the PARTNER trial.

Declaration of interest

FunctionCompany
Information not available at the time of editing

Latest contributions

SPOTLIGHT: Standardised definitions for clinical and imaging endpoints after surgical and transcatheter valve intervention

In this presentation from PCR London Valves 2017, A. Baumbach, D. Capodanno, A. Lansky, M.B. Leon and N. Piazza focus on the durability, structural deterioration and valve failure, the neurological adverse events and on what really matters in clinical and patient-reported endpoints after surgical and transcatheter valve interventions.

Beyond guidelines - Emerging indications for TAVI

26 Sep 2017 – From PCR London Valves 2017

Consult this session to be updated with the latest news on TAVI, in particular in asymptomatic patients and aortic stenosis and find out the pro and contra arguments for the extension of the indications.

Going beyond boundaries in structural heart interventions?

25 Sep 2017 – From PCR London Valves 2017

Transcatheter heart valve therapies for all heart valves: from an innovation strategy to mainstream therapy

24 Sep 2017 – From PCR London Valves 2017

Transcatheter mitral valve replacement - Part II

25 Sep 2017 – From PCR London Valves 2017

Late-breaking TAVI trials

25 Sep 2017 – From PCR London Valves 2017

LIVE demonstration from San Raffaele Scientific Institute Milan: percutaneous direct mitral annuloplasty

25 Sep 2017 – From PCR London Valves 2017

First-in-man studies in tricuspid intervention and myocardial protection

18 May 2017 – From EuroPCR 2017

Consult this session on the First-in-man studies in tricuspid intervention and myocardial protection by P. Denti, T. Koyama, A. Lauten, M.B. Leon, J.L. Navia, L. Otterspoor and R. Schueler if you want to find out more about the MitraClip system, Caval Valve Implantation, novel transcatheter tricuspid valve and more.

Planned and ongoing clinical trials on valvular intervention

18 May 2017 – From EuroPCR 2017

Firehawk DES: proven fast healing from TARGET clinical programme

17 May 2017 – From EuroPCR 2017

Bioresorbable valve therapy: tomorrow's world

17 May 2017 – From EuroPCR 2017

TRIALIGN: the new era of tricuspid repair

16 May 2017 – From EuroPCR 2017

Mitral and tricuspid

19 May 2016 – From EuroPCR 2016

Dr. Nicolo Piazza

Chairperson

Nicolo Piazza
Dr. Alec Vahanian

Chairperson

Alec Vahanian

TAVI with the Edwards family of valves has emerged as a fast, predictable & robust procedure with proven durability

20 Sep 2015 – From PCR London Valves 2015

This video is offered by Edwards Lifesciences

Thierry Lefèvre

Chairperson

Thierry Lefèvre

Chairperson

Hermann Reichenspurner

Tricuspid repair with the Trialign system

20 Sep 2016 – From PCR London Valves 2016

Dr. Martin B. Leon

Chairperson

Martin B. Leon

LIVE demonstration: Making TAVI simple in lower-risk patients

19 Sep 2016 – From PCR London Valves 2016

Darren Mylotte

Chairperson

Darren Mylotte
Prof. Olaf Wendler

Chairperson

Olaf Wendler

Moving TAVI to lower-risk populations

19 Sep 2016 – From PCR London Valves 2016

Darren Mylotte

Chairperson

Darren Mylotte
Prof. Olaf Wendler

Chairperson

Olaf Wendler

Extending the indications for TAVI to patients with asymptomatic severe aortic stenosis

20 Sep 2016 – From PCR London Valves 2016

Dr. Martin B. Leon

Chairperson

Martin B. Leon

Chairperson

Philippe Pibarot

Theme 2: innovation in percutaneous mitral valve replacement

18 Sep 2016 – From PCR London Valves 2016

Vinayak Bapat

Chairperson

Vinayak Bapat
Prof. Ran Kornowski

Chairperson

Ran Kornowski

TAVI: current and future perspectives for adjunctive antithrombotic therapy

19 May 2016 – From EuroPCR 2016

This video is offered by Bayer Pharma AG

Chairperson

George Dangas

Critical appraisal of devices for the management of hypertension

18 May 2016 – From EuroPCR 2016

Dr. Felix Mahfoud

Chairperson

Felix Mahfoud
Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher

Update on new clinical trials at the Cardiovascular Research Foundation (CRF)

18 May 2016 – From EuroPCR 2016

Chairperson

Ori Ben-Yehuda
Gregg W. Stone

Chairperson

Gregg W. Stone

Evolving BRS techniques to the acute myocardial infarction patient: Elixir DESolve to Amity

17 May 2016 – From EuroPCR 2016

This video is offered by Elixir Medical

Planned and ongoing clinical trials: a status update from the Cardiovascular Research Foundation (CRF)

21 May 2015 – From EuroPCR 2015

Chairperson

Ori Ben-Yehuda

Interventional hypertension treatment - Moving forward

20 May 2015 – From EuroPCR 2015

An update on TAVI data

30 Sep 2014 – From PCR London Valves 2014

Michael Mack

Chairperson

Michael Mack
N. Van Mieghem

Chairperson

Nicolas Van Mieghem

Timing of TAVI in the elderly with severe AS: as the procedural risk falls do we really need to wait for symptoms?

30 Sep 2014 – From PCR London Valves 2014

Chairperson

Jimmy Hon
Dr. Alec Vahanian

Chairperson

Alec Vahanian

TAVI in low gradient aortic stenosis with very poor left ventricular function: always, sometimes or never?

22 May 2014 – From EuroPCR 2014

Prof. Alain Cribier

Chairperson

Alain Cribier
Dr. Martin B. Leon

Chairperson

Martin B. Leon

Tryton IDE study outcomes: the change in daily practice treating bifurcations

22 May 2014 – From EuroPCR 2014

Renal denervation and the Vessix global clinical programme - Current learning leading to future horizons

22 May 2014 – From EuroPCR 2014

Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher
Dr. Felix Mahfoud

Chairperson

Felix Mahfoud